Computed tomography pulmonary angiography (CTPA) is the imaging modality of choice for the diagnosis of acute pulmonary embolism (PE). With computed tomography pulmonary perfusion (CTPP) additional information on lung perfusion can be assessed, but its value in PE risk stratification is unknown. We aimed to evaluate the correlation between CTPP-assessed perfusion defect score (PDS) and clinical presentation and its predictive value for adverse short-term outcome of acute PE. This was an exploratory, observational study in 100 hemodynamically stable patients with CTPA-confirmed acute PE in whom CTPP was performed as part of routine clinical practice. We calculated the difference between the mean PDS in patients with versus without chest pain, dyspnea, and hemoptysis and 7-day adverse outcome. Multivariable logistic regression analysis and likelihood-ratio test were used to assess the added predictive value of PDS to CTPA parameters of right ventricle dysfunction and total thrombus load, for intensive care unit admission, reperfusion therapy and PE-related death. We found no correlation between PDS and clinical symptoms. PDS was correlated to reperfusion therapy ( = 4 with 16% higher PDS, 95% confidence interval [CI]: 3.5-28%) and PE-related mortality ( = 2 with 22% higher PDS, 95% CI: 4.9-38). Moreover, PDS had an added predictive value to CTPA assessment for PE-related mortality (from Chi-square 14 to 19, = 0.02). CTPP-assessed PDS was not correlated to clinical presentation of acute PE. However, PDS was correlated to reperfusion therapy and PE-related mortality and had an added predictive value to CTPA-reading for PE-related mortality; this added value needs to be demonstrated in larger studies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875679 | PMC |
http://dx.doi.org/10.1055/s-0041-1723782 | DOI Listing |
J Imaging
December 2024
Radiology Department, Clinica Universidad de Navarra, Calle Santa Marta n. 1, 28027 Madrid, Spain.
The purpose of this study is to conduct a literature review on the current role of computed tomography pulmonary angiography (CTPA) in the diagnosis and prognosis of pulmonary embolism (PE). It addresses key topics such as the quantification of the thrombotic burden, its role as a predictor of mortality, new diagnostic techniques that are available, the possibility of analyzing the thrombus composition to differentiate its evolutionary stage, and the applicability of artificial intelligence (AI) in PE through CTPA. The only finding from CTPA that has been validated as a prognostic factor so far is the right ventricle/left ventricle (RV/LV) diameter ratio being >1, which is associated with a 2.
View Article and Find Full Text PDFBiosensors (Basel)
November 2024
Department of Biomedical Engineering, Texas A&M University, 5045 Emerging Technologies Building, College Station, TX 77843, USA.
J Intensive Care
November 2024
Department of Cardiology, Hirakata Kohsai Hospital, 1-2-1, Fujisakashigashimachi, Hirakata-shi, Osaka, 573-0153, Japan.
J Racial Ethn Health Disparities
October 2024
Department of Anesthesiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210Th Street, Bronx, NY, USA.
Background: While the National Institutes of Health emphasize integrating sex as a biological variable into research, specific considerations of sex-related differences in pulmonary embolism (PE) mortality trends remain scarce. This study examines sex-based PE mortality trends across regional and demographic groups in the USA from 1999 to 2020.
Methods: A retrospective analysis of National Center for Health Statistics mortality data from 1999 to 2020 was conducted.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!